pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3192 |
Genomic Coordinates | chr20: 18470615 - 18470691 |
Description | Homo sapiens miR-3192 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3192-5p | |||||||||||||||||||||||||||
Sequence | 10| UCUGGGAGGUUGUAGCAGUGGAA |32 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | DDX19A | ||||||||||||||||||||
Synonyms | DDX19-DDX19L, DDX19L | ||||||||||||||||||||
Description | DEAD-box helicase 19A | ||||||||||||||||||||
Transcript | NM_018332 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on DDX19A | |||||||||||||||||||||
3'UTR of DDX19A (miRNA target sites are highlighted) |
>DDX19A|NM_018332|3'UTR 1 GAAGCTCCACCAGCCACTGATGCCAGCCCTGGCACTGCCCCTGCACAGGAGACAAGTGCATTTAGGGCACAGGCCCCGAC 81 ATCACCCCAAGGACAACGGCAGAAGTAGAGAGAAACTACCTACCTCACTTCAAATTATGTTTGGACTTGACAAAAATAGG 161 TGCAAATGATGGGGGGCAATAGAAGAAAAAATTTGCATTTTGGAAAATTGGGTCCTTTCCCCACTTTTTTAAAGCCACAT 241 TCCCCCATCTTTATAATAATCTGGTCACAGTGGTAGTCGCTGGCCCCAGGACCCCCTCCTGATTTTGGCTAGGCATCGTG 321 GAACCAGCTCCAGCCCCTGAAGAAACGATAGATGTGCAGGTTGTGCGGAAGAGGCTGAGTGGAAAATGGTGTGAGCCCCA 401 CCGCTGTGCATCGAATGAGGGAAGTGGCAGCAGAGAGGCCAGAGCTGCCCCCTCTCTGTCTCTTCAATGGACCCTTCACA 481 AGTGTTTCTCCTGCCCTTGGGGCTGTCTTCCTTCTCCTGAAATCCAGAGACTTTCTTGCTCATCCCTTCTCCCTTTCACT 561 TCTGTTCTCTGCTGCAGAAAGCAGACTTGCATATCCCTGATGAGCAGCTCGGCTACTTTTGTAAACTTCAGATTTGGAGA 641 GAAACACGAAAGTCTGAATCCTGACCCCTTGAGAGAGAGTGATCTGGCGAGGGCCGATGAAGGGGCTGGGCCTGGTCTTG 721 CCTTCTCTTCTCTCGGTTGCTCCCTCTGCCTAGGCCCCTGGTACTCAGTCACGGCAGCCAGGAGACCCCAGGTGAGTTTC 801 TGAGCGCATACGTAGTTGGTTCTTACCCCCAGGTGTCACACGGGGCCGAGAGCTGAGCAAGAATTTGGAATGGAAGTTAT 881 GACCAAGGGAATTATGCTGTTCATTTATAATAGTGGACATTATGGAGAGCTCTGATTCCTACATAATATGAATAAGGATG 961 GATAGGCCGGGCGTGGTGGCTCATGCCTATAATCCCAGCACGTTGGGAGGCTGAGGCGGGCGGATCGGTTGAGCTCAGGC 1041 GTTCGGGACCAGCCTGGCCAACATGATGAAACCCCGTCTCTACCAAAAATAGAAAAAAATATAGCCGGGCCTGGTGGCGC 1121 ACGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGTAGGAGGATCGCTTGAGCCTGGGTAGAGGCTGCTGTGAGCTGAAAT 1201 GGCGCCACTGCACTCCAGCCTGGGTAACAGAGCGAGACCCCGACTCAATAAATAAATAAGGATGGATAAATTGTAGCGTA 1281 TGCACCATTCATTATGCTAAGACATTTTAAAGTAATTATGAGAAACGCTCTACTAATGATTTGTTTTTATTTGTATTTTT 1361 CTGCTTATTAGACAAATATATACTCATTTTAAAAAGGAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 55308.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714646. RNA binding protein: AGO2. Condition:mildMNase
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760628. RNA binding protein: AGO2. Condition:AGO-CLIP-LAPC4_B
PAR-CLIP data was present in SRX1760631. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_B
PAR-CLIP data was present in SRX1760638. RNA binding protein: AGO2. Condition:AGO-CLIP-PC3-miR148
PAR-CLIP data was present in SRX1760630. RNA binding protein: AGO2. Condition:AGO-CLIP-22RV1_A
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM714646 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / mildMNase, repA |
Location of target site | ENST00000302243.7 | 3UTR | AUCUCGGCCCACUGCAACCUCUGCCUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000302243.7 | 3UTR | AUCUCGGCCCACUGCAACCUCUGCCUCCCAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
167 hsa-miR-3192-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT058548 | CTTNBP2NL | CTTNBP2 N-terminal like | ![]() |
![]() |
2 | 2 | ||||||
MIRT139892 | BTF3L4 | basic transcription factor 3 like 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT207395 | MAT2A | methionine adenosyltransferase 2A | ![]() |
![]() |
2 | 6 | ||||||
MIRT294640 | ZNF548 | zinc finger protein 548 | ![]() |
![]() |
2 | 2 | ||||||
MIRT324251 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT441475 | BEST3 | bestrophin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT445233 | SRGAP2 | SLIT-ROBO Rho GTPase activating protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446763 | ZNF491 | zinc finger protein 491 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451003 | EPS15L1 | epidermal growth factor receptor pathway substrate 15 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452436 | QDPR | quinoid dihydropteridine reductase | ![]() |
![]() |
2 | 2 | ||||||
MIRT452582 | ZFP69B | ZFP69 zinc finger protein B | ![]() |
![]() |
2 | 2 | ||||||
MIRT452950 | DISC1 | disrupted in schizophrenia 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453309 | ZNF394 | zinc finger protein 394 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453810 | KBTBD12 | kelch repeat and BTB domain containing 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454101 | TMEM209 | transmembrane protein 209 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456228 | LIX1L | limb and CNS expressed 1 like | ![]() |
![]() |
2 | 4 | ||||||
MIRT456738 | TMEM239 | transmembrane protein 239 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456806 | SIGLEC14 | sialic acid binding Ig like lectin 14 | ![]() |
![]() |
2 | 4 | ||||||
MIRT457499 | SLC35F6 | solute carrier family 35 member F6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458037 | MRPL12 | mitochondrial ribosomal protein L12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459041 | ZNF490 | zinc finger protein 490 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459135 | FADS6 | fatty acid desaturase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT460126 | CXCL16 | C-X-C motif chemokine ligand 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT460506 | FAM105A | family with sequence similarity 105 member A | ![]() |
![]() |
2 | 6 | ||||||
MIRT460944 | NOA1 | nitric oxide associated 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT461101 | OPA3 | OPA3, outer mitochondrial membrane lipid metabolism regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT462641 | PHF5A | PHD finger protein 5A | ![]() |
![]() |
2 | 2 | ||||||
MIRT463584 | ZBTB38 | zinc finger and BTB domain containing 38 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466567 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467090 | SRRD | SRR1 domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT471093 | PIK3C2B | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT472596 | NACC1 | nucleus accumbens associated 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT473084 | MORN4 | MORN repeat containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475977 | GTPBP2 | GTP binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477054 | FAM210A | family with sequence similarity 210 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT478303 | DDX19A | DEAD-box helicase 19A | ![]() |
![]() |
2 | 4 | ||||||
MIRT478489 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478500 | CYP1B1 | cytochrome P450 family 1 subfamily B member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT478858 | CRISPLD2 | cysteine rich secretory protein LCCL domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479096 | CNNM4 | cyclin and CBS domain divalent metal cation transport mediator 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479180 | CLSPN | claspin | ![]() |
![]() |
2 | 2 | ||||||
MIRT479215 | CLCC1 | chloride channel CLIC like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT481176 | AVL9 | AVL9 cell migration associated | ![]() |
![]() |
2 | 6 | ||||||
MIRT483032 | KHSRP | KH-type splicing regulatory protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT485150 | RASL10B | RAS like family 10 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT486104 | SLC7A5 | solute carrier family 7 member 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT486319 | SIPA1 | signal-induced proliferation-associated 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489443 | IFNLR1 | interferon lambda receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489585 | SSBP2 | single stranded DNA binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT489702 | SCAMP4 | secretory carrier membrane protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490184 | TMEM63C | transmembrane protein 63C | ![]() |
![]() |
2 | 2 | ||||||
MIRT491211 | MLLT1 | MLLT1, super elongation complex subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT491276 | DHX40 | DEAH-box helicase 40 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495162 | CNGA2 | cyclic nucleotide gated channel alpha 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT495222 | DSCR3 | DSCR3 arrestin fold containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT496820 | CHRNB2 | cholinergic receptor nicotinic beta 2 subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT498602 | KRT8 | keratin 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT500003 | HIST1H2BD | histone cluster 1 H2B family member d | ![]() |
![]() |
2 | 4 | ||||||
MIRT502065 | KRAS | KRAS proto-oncogene, GTPase | ![]() |
![]() |
2 | 2 | ||||||
MIRT508197 | SLC35E1 | solute carrier family 35 member E1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT508477 | FAM71F2 | family with sequence similarity 71 member F2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT509635 | RRP7A | ribosomal RNA processing 7 homolog A | ![]() |
![]() |
2 | 4 | ||||||
MIRT511039 | NRF1 | nuclear respiratory factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT516684 | ZNF860 | zinc finger protein 860 | ![]() |
![]() |
2 | 4 | ||||||
MIRT518394 | ZNF250 | zinc finger protein 250 | ![]() |
![]() |
2 | 2 | ||||||
MIRT518907 | CDC14B | cell division cycle 14B | ![]() |
![]() |
2 | 2 | ||||||
MIRT520502 | TRAM2 | translocation associated membrane protein 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT521459 | RAD51 | RAD51 recombinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT522354 | NCKIPSD | NCK interacting protein with SH3 domain | ![]() |
![]() |
2 | 4 | ||||||
MIRT522594 | MAPK1IP1L | mitogen-activated protein kinase 1 interacting protein 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT523267 | HIST1H2AE | histone cluster 1 H2A family member e | ![]() |
![]() |
2 | 2 | ||||||
MIRT523532 | GLUL | glutamate-ammonia ligase | ![]() |
![]() |
2 | 4 | ||||||
MIRT524186 | DFFA | DNA fragmentation factor subunit alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT526842 | PHC1 | polyhomeotic homolog 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528729 | FAM26E | calcium homeostasis modulator family member 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT540695 | BMP3 | bone morphogenetic protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544483 | TRIM4 | tripartite motif containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT551566 | LETM1 | leucine zipper and EF-hand containing transmembrane protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563619 | ZNF277 | zinc finger protein 277 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564467 | SLC35E2 | solute carrier family 35 member E2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565031 | VAV2 | vav guanine nucleotide exchange factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570294 | ARPC3 | actin related protein 2/3 complex subunit 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT572932 | VDAC2 | voltage dependent anion channel 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573501 | IQSEC3 | IQ motif and Sec7 domain 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573675 | HES6 | hes family bHLH transcription factor 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT609619 | TRPC4AP | transient receptor potential cation channel subfamily C member 4 associated protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT611966 | PKD1 | polycystin 1, transient receptor potential channel interacting | ![]() |
![]() |
2 | 2 | ||||||
MIRT613930 | HIVEP3 | human immunodeficiency virus type I enhancer binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT617733 | ATCAY | ATCAY, caytaxin | ![]() |
![]() |
2 | 4 | ||||||
MIRT618878 | MBL2 | mannose binding lectin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT627590 | SHROOM3 | shroom family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT628516 | ZNF878 | zinc finger protein 878 | ![]() |
![]() |
2 | 2 | ||||||
MIRT633964 | GRWD1 | glutamate rich WD repeat containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634530 | NEGR1 | neuronal growth regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT635455 | APOLD1 | apolipoprotein L domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT636412 | MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase | ![]() |
![]() |
2 | 2 | ||||||
MIRT639672 | PPEF2 | protein phosphatase with EF-hand domain 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT642667 | RGS6 | regulator of G protein signaling 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT644080 | A4GALT | alpha 1,4-galactosyltransferase (P blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT647318 | RPH3AL | rabphilin 3A like (without C2 domains) | ![]() |
![]() |
2 | 2 | ||||||
MIRT647942 | RNF152 | ring finger protein 152 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648687 | AP1M1 | adaptor related protein complex 1 mu 1 subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT648817 | ZNF689 | zinc finger protein 689 | ![]() |
![]() |
2 | 2 | ||||||
MIRT650347 | TREM1 | triggering receptor expressed on myeloid cells 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT650374 | MOCS3 | molybdenum cofactor synthesis 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT655935 | NDUFA4P1 | NDUFA4, mitochondrial complex associated pseudogene 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663778 | PEX26 | peroxisomal biogenesis factor 26 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664297 | HINT1 | histidine triad nucleotide binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT665842 | TIAL1 | TIA1 cytotoxic granule associated RNA binding protein like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT668929 | COL9A2 | collagen type IX alpha 2 chain | ![]() |
![]() |
2 | 2 | ||||||
MIRT669673 | ACAP2 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669907 | KIAA0754 | KIAA0754 | ![]() |
![]() |
2 | 4 | ||||||
MIRT670248 | TRIM13 | tripartite motif containing 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT670368 | ULBP3 | UL16 binding protein 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT670642 | BVES | blood vessel epicardial substance | ![]() |
![]() |
2 | 2 | ||||||
MIRT670749 | HOOK3 | hook microtubule tethering protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT671184 | ZNF891 | zinc finger protein 891 | ![]() |
![]() |
2 | 2 | ||||||
MIRT673946 | ZNF500 | zinc finger protein 500 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674682 | PLCE1 | phospholipase C epsilon 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT677912 | HIST1H2BN | histone cluster 1 H2B family member n | ![]() |
![]() |
2 | 2 | ||||||
MIRT678876 | FAM118A | family with sequence similarity 118 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT679528 | RAB36 | RAB36, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT680589 | ZNF573 | zinc finger protein 573 | ![]() |
![]() |
2 | 2 | ||||||
MIRT680650 | KIAA1456 | KIAA1456 | ![]() |
![]() |
2 | 2 | ||||||
MIRT681149 | INTS7 | integrator complex subunit 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT681177 | IBA57 | IBA57 homolog, iron-sulfur cluster assembly | ![]() |
![]() |
2 | 2 | ||||||
MIRT681234 | DUSP19 | dual specificity phosphatase 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT681626 | F2RL2 | coagulation factor II thrombin receptor like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT681643 | SCRG1 | stimulator of chondrogenesis 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT681926 | KAT7 | lysine acetyltransferase 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT682050 | MRPS10 | mitochondrial ribosomal protein S10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT682156 | SMS | spermine synthase | ![]() |
![]() |
2 | 2 | ||||||
MIRT683555 | HAVCR1 | hepatitis A virus cellular receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684304 | TRUB2 | TruB pseudouridine synthase family member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684458 | MFSD4 | major facilitator superfamily domain containing 4A | ![]() |
![]() |
2 | 2 | ||||||
MIRT685986 | CCDC77 | coiled-coil domain containing 77 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686782 | AZF1 | azoospermia factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT687329 | OSMR | oncostatin M receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT687629 | LRIG2 | leucine rich repeats and immunoglobulin like domains 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT688792 | CCNB1 | cyclin B1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT689756 | PRR13 | proline rich 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT690823 | SGSM2 | small G protein signaling modulator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT691310 | ZNF681 | zinc finger protein 681 | ![]() |
![]() |
2 | 2 | ||||||
MIRT692676 | ZMYM1 | zinc finger MYM-type containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT693508 | MOB3A | MOB kinase activator 3A | ![]() |
![]() |
2 | 2 | ||||||
MIRT694657 | C14orf119 | chromosome 14 open reading frame 119 | ![]() |
![]() |
2 | 2 | ||||||
MIRT694889 | ZNF417 | zinc finger protein 417 | ![]() |
![]() |
2 | 2 | ||||||
MIRT695740 | ZNF117 | zinc finger protein 117 | ![]() |
![]() |
2 | 2 | ||||||
MIRT697101 | GPKOW | G-patch domain and KOW motifs | ![]() |
![]() |
2 | 2 | ||||||
MIRT698968 | SPAST | spastin | ![]() |
![]() |
2 | 2 | ||||||
MIRT700379 | RAB33B | RAB33B, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT703930 | EPG5 | ectopic P-granules autophagy protein 5 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT706234 | SYT15 | synaptotagmin 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT706494 | SEPT6 | septin 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710451 | BTNL3 | butyrophilin like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711684 | ATF7IP | activating transcription factor 7 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT711997 | F9 | coagulation factor IX | ![]() |
![]() |
2 | 2 | ||||||
MIRT712727 | NCAPG2 | non-SMC condensin II complex subunit G2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713111 | TMBIM4 | transmembrane BAX inhibitor motif containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713156 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | ![]() |
![]() |
2 | 2 | ||||||
MIRT713440 | AJAP1 | adherens junctions associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713830 | NUP98 | nucleoporin 98 | ![]() |
![]() |
2 | 2 | ||||||
MIRT714979 | RAB21 | RAB21, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT717411 | ZCCHC24 | zinc finger CCHC-type containing 24 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718433 | ZNF85 | zinc finger protein 85 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720575 | SDHAF2 | succinate dehydrogenase complex assembly factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725098 | TMEM120B | transmembrane protein 120B | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|